OBJECTIVE: Atherosclerosis may be regarded as an inflammatory disease dominated by macrophages. We tested whether macrophages in carotid artery atherosclerotic plaques are associated with echolucency on B-mode ultrasound imaging, lipid levels, inflammatory markers, and aspirin use. METHODS: We studied 106 patients undergoing carotid endarterectomy having >/=50% carotid artery stenosis and previous ipsilateral hemispheric neurologic symptoms. RESULTS: Macrophages were particularly common in plaques with a high content of lipid and hemorrhage and, conversely, rare in plaques dominated by calcification and fibrous tissue. Macrophage density in carotid artery plaques classified by B-mode ultrasound imaging as echolucent (n = 56), intermediate (n = 25), or echorich (n = 25) was 1.8% +/- 0.2%, 1.5% +/- 0.4%, and 1.0% +/- 0.2% (+/-SE), respectively (analysis of variance, P =.02). A computer-generated measure of plaque echolucency, gray-scale median, was associated with increased macrophage density (r = -0.31; P =.002). Furthermore, plasma and low-density lipoprotein cholesterol levels were associated with carotid artery macrophage density (r = 0.26, P =.008 and r = 0.23, P =.02); this was most pronounced in patients with lipid-rich plaques. Macrophage density was not associated with plasma levels of acute-phase reactants. Finally, macrophage density in carotid artery plaques of users (n = 55) and nonusers of aspirin (n = 51) was 1.2% +/- 0.2% and 1.8% +/- 0.2% (t test, P =.01). CONCLUSIONS: Increased macrophage density in carotid atherosclerotic plaques was associated with lipid content, plaque echolucency, and increased plasma and low-density lipoprotein cholesterol levels. Furthermore, use of aspirin was associated with reduced macrophage density in carotid artery plaques.
OBJECTIVE:Atherosclerosis may be regarded as an inflammatory disease dominated by macrophages. We tested whether macrophages in carotid artery atherosclerotic plaques are associated with echolucency on B-mode ultrasound imaging, lipid levels, inflammatory markers, and aspirin use. METHODS: We studied 106 patients undergoing carotid endarterectomy having >/=50% carotid artery stenosis and previous ipsilateral hemispheric neurologic symptoms. RESULTS: Macrophages were particularly common in plaques with a high content of lipid and hemorrhage and, conversely, rare in plaques dominated by calcification and fibrous tissue. Macrophage density in carotid artery plaques classified by B-mode ultrasound imaging as echolucent (n = 56), intermediate (n = 25), or echorich (n = 25) was 1.8% +/- 0.2%, 1.5% +/- 0.4%, and 1.0% +/- 0.2% (+/-SE), respectively (analysis of variance, P =.02). A computer-generated measure of plaque echolucency, gray-scale median, was associated with increased macrophage density (r = -0.31; P =.002). Furthermore, plasma and low-density lipoprotein cholesterol levels were associated with carotid artery macrophage density (r = 0.26, P =.008 and r = 0.23, P =.02); this was most pronounced in patients with lipid-rich plaques. Macrophage density was not associated with plasma levels of acute-phase reactants. Finally, macrophage density in carotid artery plaques of users (n = 55) and nonusers of aspirin (n = 51) was 1.2% +/- 0.2% and 1.8% +/- 0.2% (t test, P =.01). CONCLUSIONS: Increased macrophage density in carotid atherosclerotic plaques was associated with lipid content, plaque echolucency, and increased plasma and low-density lipoprotein cholesterol levels. Furthermore, use of aspirin was associated with reduced macrophage density in carotid artery plaques.
Authors: Wei Chen; David P Cormode; Yuliya Vengrenyuk; Beatriz Herranz; Jonathan E Feig; Ahmed Klink; Willem J M Mulder; Edward A Fisher; Zahi A Fayad Journal: JACC Cardiovasc Imaging Date: 2013-02-20
Authors: Cheuk F Chan; Niall G Keenan; Sonia Nielles-Vallespin; Peter Gatehouse; Mary N Sheppard; Joseph J Boyle; Dudley J Pennell; David N Firmin Journal: J Cardiovasc Magn Reson Date: 2010-03-26 Impact factor: 5.364
Authors: Stephen J Murphy; Soon T Lim; Justin A Kinsella; Sean Tierney; Bridget Egan; Tim M Feeley; Clare Dooley; James Kelly; Sinead M Murphy; Richard A Walsh; Ronan Collins; Tara Coughlan; Desmond O'Neill; Joseph A Harbison; Prakash Madhavan; Sean M O'Neill; Mary P Colgan; Jim F Meaney; George Hamilton; Dominick Jh McCabe Journal: J Cereb Blood Flow Metab Date: 2019-11-11 Impact factor: 6.200
Authors: Joseph A Delaney; Nils Lehmann; Karl-Heinz Jöckel; Sammy Elmariah; Bruce M Psaty; Amir A Mahabadi; Matt Budoff; Richard A Kronmal; Khurram Nasir; Kevin D O'Brien; Stefan Möhlenkamp; Susanne Moebus; Nico Dragano; Almut G Winterstein; Raimund Erbel; Hagen Kälsch Journal: Atherosclerosis Date: 2013-05-14 Impact factor: 5.162
Authors: Anoop K Patel; Harman S Suri; Jaskaran Singh; Dinesh Kumar; Shoaib Shafique; Andrew Nicolaides; Sanjay K Jain; Luca Saba; Ajay Gupta; John R Laird; Argiris Giannopoulos; Jasjit S Suri Journal: Curr Atheroscler Rep Date: 2016-12 Impact factor: 5.113
Authors: Tomasz J Czernuszewicz; Jonathon W Homeister; Melissa C Caughey; Mark A Farber; Joseph J Fulton; Peter F Ford; William A Marston; Raghuveer Vallabhaneni; Timothy C Nichols; Caterina M Gallippi Journal: Ultrasound Med Biol Date: 2015-01-22 Impact factor: 2.998
Authors: Børge G Nordestgaard; Stephen J Nicholls; Anne Langsted; Kausik K Ray; Anne Tybjærg-Hansen Journal: Nat Rev Cardiol Date: 2018-02-08 Impact factor: 32.419